Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients

Acta Neurologica Scandinavica

Volumn 104, Issue 2, 2001, Pages 83-87

  De Andres C ^a   Guillem, A ^a   Rodriguez Mahou M ^a   Lopez Longo F J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Anti Ro (SS A) antibodies; Anticardiolipin antibodies; Antinuclear antibodies; Demyelinating disease; Multiple sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; MULTIPLE SCLEROSIS; SALIVARY GLAND;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SJOGREN'S SYNDROME;

EID: 0034781352     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2001.104002083.x     Document Type: Article

References (44)

1. Multiple sclerosis and chronic inflammatory diseases
2. Neurologic disease in Sjögren's syndrome
3. The 1982 revised criteria for the classification of systemic lupus erythematosus
4. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community
5. The antiphospholipid syndrome: Ten years on
6. Autoantibodies in the diagnosis of the systemic rheumatic diseases
7. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome: Clinical, neuroimaging and angiographic correlates
8. New diagnostic criteria for multiple sclerosis: Guideline for research protocols
9. Rating neurological impairment in multiple sclerosis and Expanded Disability Status Scale (EDSS)
10. AntiBB'-Sm antibodies, anticardiolipin antibodies and thrombosis in systemic lupus erythematosus
11. Heterogeneity of the anti-Ro (SS-A) response in rheumatic diseases
12. Systemic lupus erythematosus: Clinical expression and anti-Ro (SS-A) response in patients with and without lesions of subacute cutaneous lupus erythematosus
13. Systemic autoimmune features and multiple sclerosis: A 5-year follow-up study
14. Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisolone and azathioprine
15. Autoimmunity in multiple sclerosis: Study of a wide spectrum of autoantibodies
16. Autoreactive IgG to intracellular proteins in sera of MS patients
17. No increase of serum antibodies during therapy with recombinant human interferon-β1a in relapsing-remitting multiple sclerosis
18. No evidence for incresased frequency of autoantibodies during interferon-β1b treatment of multiple sclerosis
19. Systemic lupus erythematosus: Clinical features
20. Central nervous system disease in Sjögren's syndrome: New insights into immunopathogenesis
21. The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus
22. Primary Sjögren's syndrome with central nervous system dysfunction mimicking multiple sclerosis
23. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome
24. Aseptic meningoencephalitis in primary Sjögren's syndrome
25. Neuromuscular complications of primary Sjögren's syndrome
26. Optic neuropathy as an initial manifestation of Sjögren's syndrome
27. The spectrum of neurological involvement in Sjögren's syndrome
28. The prevalence of primary Sjögren's syndrome in multiple sclerosis population
29. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis
30. Frequency of antinuclear antibodies in multiple sclerosis
31. Los anticuerpos antinucleares en la esclerosis múltiple
32. Frequency and significance of antinuclear antibodies in multiple sclerosis
33. Sclerose en plaques et anticorps antiphospholipides: Étude consecutive de 62 patients
34. Antinuclear antibodies and the optic-spinal form of multiple sclerosis
35. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?
36. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: Multiple sclerosis or antiphospholipid syndrome?
37. Nervous system manifestations in Sjögren's syndrome
38. Anti-Ro (SS-A) and anti-La (SS-B) antibodies in patients with Sjögren's syndrome
39. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA and SSB)
40. Fine specificity of anti-Ro (SS-A) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus
41. Clinical significance of antibodies to native or denatured 60 KD or 52 KD Ro (SS-A) proteins in Sjögren's syndrome
42. Detection of anti-Ro (SS-A) antibodies in autoimmune diseases: Comparison of five methods